HPE
63
2
BK
74
2
SNA
68
-2
IPG
56
3
USB
55
-6
VMC
57
4
FE
50
-2
NEE
50
-5
CINF
53
2
NWL
53
3
FITB
63
3
NVDA
56
-4
ADBE
49
3
ADT
53
3
DNB
82
4
GS
75
2
NSC
60
3
CA
38
6
PPL
54
-5
INTC
33
-2
HPE
63
2
BK
74
2
SNA
68
-2
IPG
56
3
USB
55
-6
VMC
57
4
FE
50
-2
NEE
50
-5
CINF
53
2
NWL
53
3
FITB
63
3
NVDA
56
-4
ADBE
49
3
ADT
53
3
DNB
82
4
GS
75
2
NSC
60
3
CA
38
6
PPL
54
-5
INTC
33
-2
Financhill
Back

Range Cancer Therapeutics ETF Vs. First Trust Nasdaq Pharmaceuticals ETF Industry Stock Comparison

Sell
47

CNCR
Range Cancer Therapeutics ETF

Last Price:
13.62
Seasonality Move:
2.55%
Sell
41

FTXH
First Trust Nasdaq Pharmaceuticals ETF

Last Price:
27.74
Seasonality Move:
4.46%
Sell
47
Range Cancer Therapeutics ETF (CNCR) is a Sell

Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Cancer Therapeutics ETF [CNCR] share price is $13.56. The Score for CNCR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
First Trust Nasdaq Pharmaceuticals ETF (FTXH) is a Sell

Is First Trust Nasdaq Pharmaceuticals ETF a Buy, Sell or Hold?

  • The current First Trust Nasdaq Pharmaceuticals ETF [FTXH] share price is $28.09. The Score for FTXH is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • FTXH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CNCR Stock Price Chart

What is Range Cancer Therapeutics ETF's stock price today?

  • The Range Cancer Therapeutics ETF share price today is $13.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing slight buying pressure.

FTXH Stock Price Chart

What is First Trust Nasdaq Pharmaceuticals ETF's stock price today?

  • The First Trust Nasdaq Pharmaceuticals ETF share price today is $28.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FTXH is experiencing buying pressure, which is a positive indicator for future bullish movement.

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.43 Sell
Relative Strength Index (14 RSI): 36.72 Sell
Chaikin Money Flow: 1180 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.87 - 15.47) Sell
Bollinger Bands (100): (14.08 - 15.46) Sell

FTXH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 48.86 Sell
Chaikin Money Flow: 958 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.64 - 28.74) Sell
Bollinger Bands (100): (27.95 - 29.15) Sell

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.68 Sell
20-day SMA: 14.6 Sell
50-day SMA: 14.86 Sell
200-day SMA: 15.05 Sell
8-day EMA: 13.76 Sell
20-day EMA: 14.32 Sell
50-day EMA: 14.66 Sell
200-day EMA: 14.55 Sell

FTXH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.64 Buy
20-day SMA: 28.17 Sell
50-day SMA: 28.51 Sell
200-day SMA: 27.84 Buy
8-day EMA: 27.79 Buy
20-day EMA: 28.06 Buy
50-day EMA: 28.33 Sell
200-day EMA: 27.88 Buy

Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

First Trust Nasdaq Pharmaceuticals ETF Earnings Growth & FTXH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Range Cancer Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

First Trust Nasdaq Pharmaceuticals ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):